Methods and compositions for intraocular administration to treat ocular conditions
US8642067B2 · kind B2 · utility
4Cited by
62References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2007 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Nov 3, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-angiogenesis compositions, and methods of using such compositions, useful for injection into the vitreous of human eyes are provided. Such compositions can include TKI component solutions or particles present in a therapeutically effective amount, a viscosity inducing component, and an aqueous carrier component. The compositions have viscosities at about 25° C. of at least about 10 cps or about 100 cps at a shear rate of 0.1/second. In a preferred embodiment, the viscosity at 25° C. is in the range of from about 80,000 cps to about 300,000 cps.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.